EC Number | Application | Comment | Organism |
---|---|---|---|
1.1.1.62 | medicine | target for suppression of estrogen synthesis in breast cancer | Homo sapiens |
EC Number | Crystallization (Comment) | Organism |
---|---|---|
1.1.1.62 | hanging drop vapor diffusion method | Homo sapiens |
EC Number | Inhibitors | Comment | Organism | Structure |
---|---|---|---|---|
1.1.1.62 | EM-1745 | strong competitive inhibitor, inhibition reversible, 50% inhibition at 52 nM | Homo sapiens |
EC Number | Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
1.1.1.62 | estrone + NADPH + H+ | Homo sapiens | final step in the synthesis of active estrogens | estradiol-17beta + NADP+ | - |
? |
EC Number | Organism | UniProt | Comment | Textmining |
---|---|---|---|---|
1.1.1.62 | Homo sapiens | P14061 | isotype 1, 17beta-HSD type 1 | - |
EC Number | Purification (Comment) | Organism |
---|---|---|
1.1.1.62 | - |
Homo sapiens |
EC Number | Source Tissue | Comment | Organism | Textmining |
---|---|---|---|---|
1.1.1.62 | placenta | - |
Homo sapiens | - |
EC Number | Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
1.1.1.62 | 5-androstene-3beta-ol-17-one + NADPH | - |
Homo sapiens | 5-androstene-3beta,17beta-diol + NADP+ | - |
? | |
1.1.1.62 | estrone + NADPH + H+ | - |
Homo sapiens | estradiol-17beta + NADP+ | - |
? | |
1.1.1.62 | estrone + NADPH + H+ | final step in the synthesis of active estrogens | Homo sapiens | estradiol-17beta + NADP+ | - |
? |
EC Number | Cofactor | Comment | Organism | Structure |
---|---|---|---|---|
1.1.1.62 | NADPH | - |
Homo sapiens |
EC Number | Ki Value [mM] | Ki Value maximum [mM] | Inhibitor | Comment | Organism | Structure |
---|---|---|---|---|---|---|
1.1.1.62 | 0.000003 | - |
EM-1745 | pH 7.5, 37°C | Homo sapiens |